Hannover Ruckversich (HVRRY) 49.9000 $HVRRY Aon's

New Post Public Reply Private Reply Replies (0) Message Board

Jul 10, 2016 at 3:11 AM

Hannover Ruckversich (HVRRY) 49.9000 $HVRRY

Aon's Business Strengthening Initiatives, Buyouts Impress
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 10:01AM CDT
On Jul 4, 2016, we issued an updated research report on Aon Plc (AON).
BRO: 37.34 (+0.55), BCRH: 18.14 (unch), AON: 109.57 (+0.62)

Willis Towers (WLTW) Sees Merger Synergies: Time to Hold?
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 9:01AM CDT
On Jun 28, 2016, we issued an updated research report on Willis Towers Watson plc (WLTW).
BRO: 37.34 (+0.55), WLTW: 125.06 (+0.62), MMC: 67.17 (+0.37)

Arthur J. Gallagher Strengths Foothold in North Central US
Zacks Equity Research - Zacks Investment Research - Tue Jun 14, 9:21AM CDT
Arthur J. Gallagher & Co. (AJG) has acquired The Buchholz Planning Corporation ("BPC"

to enhance its employee benefits brokerage and consulting services in the North Central region of the United States.
BRO: 37.34 (+0.55), AJG: 48.70 (+0.70), MMC: 67.17 (+0.37)

Brown & Brown Poised for Growth Despite Higher Expenses
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:20AM CDT
On Jun 10, 2016, we issued an updated research report on Brown & Brown Inc. (BRO).
BRO: 37.34 (+0.55), MKL: 947.53 (+15.23), MMC: 67.17 (+0.37)

Arthur J. Gallagher Boosts Brokerage Services with New Deal
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 9:59AM CDT
Arthur J. Gallagher & Co. (AJG) has acquired KRW Insurance Agency, Inc. to enhance its brokerage services in the Midwestern region of the United States.
BRO: 37.34 (+0.55), AJG: 48.70 (+0.70), MMC: 67.17 (+0.37)

Brown & Brown Touches 52-Week High on Strong Q1, Buyout
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:09AM CDT
On Jun 7, 2016, shares of Brown & Brown Inc. (BRO) hit a 52-week high of $36.40, driven by better-than-expected first-quarter 2016 results and strategic buyout.
BRO: 37.34 (+0.55), L: 40.78 (+0.65), MMC: 67.17 (+0.37)

Arthur J. Gallagher Adds Ashmore & Associates to its Portfolio
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 9:20AM CDT
Arthur J. Gallagher & Co. (AJG) has acquired Ashmore & Associates Insurance Agency, Inc. to enhance its brokerage services in the South Central region of the United States.
BRO: 37.34 (+0.55), AJG: 48.70 (+0.70), MMC: 67.17 (+0.37)

Willis Towers Widens Insurance Management Services Base
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 4:58PM CDT
Willis Towers Watson Public Limited Company (WLTW) recently obtained official permission from the Swiss Financial Market Supervisory Authority to provide insurance management services in Switzerland.
WLTW: 125.06 (+0.62), MKL: 947.53 (+15.23), MMC: 67.17 (+0.37)

Validus Holdings (VR) Scales 52-Week High on Strong Q1
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 8:36AM CDT
On Jun 1, 2016, shares of Validus Holdings, Ltd (VR) hit a 52-week high of $48.77, driven by better-than-expected first-quarter 2016 results.
VR: 48.30 (+0.55), MCC: 7.22 (+0.09), TRUP: 14.78 (+0.50)

Aon Reaches New 52-Week High on Strong Q1, Dividend Hike
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 9:18AM CDT
On May 31, 2016, shares of Aon plc (AON) hit a 52-week high of $109.65, driven by better-than-expected first-quarter 2016 results and dividend hike.
AON: 109.57 (+0.62), TRUP: 14.78 (+0.50), MMC: 67.17 (+0.37)

Willis Towers: Growth Prospects Bright, Expenses on the Rise
Zacks Equity Research - Zacks Investment Research - Thu May 26, 9:42AM CDT
On May 25, 2016, we issued an updated research report on Willis Towers Watson Public Limited Company (WLTW).
WLTW: 125.06 (+0.62), MKL: 947.53 (+15.23), MMC: 67.17 (+0.37)

Why Hannover Ruck (HVRRY) Could Be a Top Value Stock Pick
Zacks Equity Research - Zacks Investment Research - Mon May 23, 7:38AM CDT
Hannover may be a strong candidate for value investing, since it has a low PE, solid outlook and a decent dividend.

Arthur J. Gallagher Boosts its Services with McNeary Buyout
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:32AM CDT
Arthur J. Gallagher & Co. (AJG) announced the acquisition of McNeary, Inc. for an undisclosed amount. The deal will complement the acquirer's Southeastern property/casualty (P&C) and employee benefits operations.
AJG: 48.70 (+0.70), NMIH: 5.63 (+0.19), Y: 547.56 (+5.73)

Aon plc (AON) Poised for Growth; Forex Volatility a Drag
Zacks Equity Research - Zacks Investment Research - Tue May 17, 10:07AM CDT
On May 16, 2016, we issued an updated research report on Aon plc (AON).
CINF: 75.70 (+0.73), AON: 109.57 (+0.62), MKL: 947.53 (+15.23)

Arthur J. Gallagher Adds Hogan Insurance to its Portfolio
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:20AM CDT
Arthur J. Gallagher & Co. (AJG) announced the acquisition of Hogan Insurance Services, Inc. for an undisclosed amount to boost its Western Region brokerage operations.
BRO: 37.34 (+0.55), AJG: 48.70 (+0.70), Y: 547.56 (+5.73)

Spring Bounces Stocks with Outside Appeal: Global Week Ahead
John Blank - Zacks Investment Research - Mon Apr 25, 9:21AM CDT
With forward S&P 500 EPS valuations this rich, some new fundamental or monetary catalyst must emerge -- in a positive or negative direction -- to get the broad U.S. stock market off this level.
CENT: 23.40 (+0.27), BECN: 47.73 (+0.71)

Hannover Ruck (HVRRY): The Perfect Mix of Value and Rising Earnings Estimates?
Zacks Equity Research - Zacks Investment Research - Fri Apr 08, 7:48AM CDT
Hannover Ruck could be a great choice for value investors at this time as it has a low PE, P/S ratio, decent dividend yield and a strong Zacks Rank

Brown & Brown Eyes Long-Term Growth Despite Higher Costs
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 2:00PM CDT
On Mar 22, 2016, we issued an updated research report on Brown & Brown Inc. (BRO).
BRO: 37.34 (+0.55), BCRH: 18.14 (unch), CB: 130.24 (+1.61)

Willis Towers Watson Affiliate Prices $1 Billion Senior Notes
Zacks Equity Research - Zacks Investment Research - Mon Mar 21, 2:10PM CDT
Trinity Acquisition plc ("Trinity"

, an indirect wholly-owned subsidiary of Willis Towers Watson Public Limited Company (WLTW), has made a registered offering of two series of senior unsecured notes aggregating $1 billion.
WLTW: 125.06 (+0.62), BCRH: 18.14 (unch), CB: 130.24 (+1.61)

Willis Towers Poised for Growth Despite Low Interest Rates
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 2:20PM CDT
On Mar 14, 2016, we issued an updated research report on Willis Towers Watson Public Limited Company (WLTW).
UIHC: 15.67 (-0.08), WLTW: 125.06 (+0.62), BCRH: 18.14 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Fluence Energy Hits Legal Snag: Investors Called to Act

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...